Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary triglycerides and other lipids represent the primary source of exogenous fats in the human diet, serving as critical energy reserves and structural components of cellular membranes (StatPearls: Physiology, Triglycerides, 2023). These molecules are composed mainly of triacylglycerols, which are hydrolyzed by lipases in the gastrointestinal tract into free fatty acids and monoglycerides for absorption (NIH: Lipid Metabolism, 2023). While they are essential for physiological processes, including the transport of fat-soluble vitamins, chronically elevated levels are a major risk factor for cardiovascular disease, obesity, and pancreatitis (American Heart Association: Management of Cholesterol, 2018).\n\nIn pharmacology, dietary lipids are considered substrates rather than protein targets; therapeutic strategies focus on inhibiting the enzymes or transporters responsible for their breakdown and uptake (PubChem: Triglyceride, 2024). For instance, lipase inhibitors like Orlistat prevent the digestion of triglycerides, while other agents like Ezetimibe block the intestinal absorption of cholesterol, effectively lowering systemic lipid levels and mitigating metabolic risk (FDA: Orlistat Label, 2015; StatPearls: Ezetimibe, 2023).
Drugs targeting the processing of dietary lipids typically act by inhibiting gastrointestinal enzymes, such as pancreatic lipase, to prevent the breakdown of triglycerides into absorbable components, or by inhibiting transport proteins like NPC1L1 to block the uptake of cholesterol into enterocytes (StatPearls: Orlistat, 2023; StatPearls: Ezetimibe, 2023).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary triglycerides and other lipids (TG).